Innovative APTT Diagnostic Testing Technologies and Emerging Markets

Date: November 29, 2012
Pages: 198
Price:
US$ 3,850.00 US$ 3,272.50
License [?]:
Publisher: Venture Planning Group
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: IA11BA286F3EN
Leaflet:

Download PDF Leaflet

Innovative APTT Diagnostic Testing Technologies and Emerging Markets
This report contains 198 pages, 8 tables and presents a detailed analysis of the APTT testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice, as well as 5- and 10-year test volume forecasts by country and market segment.

The growing cost-containment pressures in major industrialized nations and continued technological advances will radically change coagulation testing practice during the next ten years. New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation. Coagulation testing in general, and APTT testing specifically, will become more standardized, offering opportunities for quality control products and services. Moreover, the continuing contraction of the hospital system and technological advances will facilitate decentralization of the APTT testing closer to the patient, creating additional opportunities and challenges for suppliers.

The report examines market applications of chromogenic substrates, monoclonal antibodies, immunoassays, IT, DNA probes, biochips/microarrays, and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks.

Contains 198 pages and 8 tables
I. INTRODUCTION

II. WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW

A. Introduction
B. Activated Partial Thromboplastin Time (APTT): Clinical Significance and Current Laboratory Procedures
C. Instrumentation Review
  Introduction
  Benk Hemolab
  Benk TRT Thrombotimer
  Bio/Data MCA 310
  Bio/Data MCA 210
  Bio/Data PAP-4C D/4D/4C
  Cardiovascular Diagnostics COAG
  Diagnostica Stago STA Compact
  Diagnostica Stago STA-R
  Diagnostica Stago Star 4/8
  Helena Laboratories Cascade 480
  Helena Laboratories Cascade M
  Helena Laboratories PACKS-4
  Helena THOR
  Instrumentation Laboratory ACL 100 and 1000 series
  Instrumentation Laboratory ACL6000
  Instrumentation Laboratory ACL7000
  Instrumentation Laboratory ACL9000
  Instrumentation Laboratory Electra 1000C
  Instrumentation Laboratory Electra 1400C
  Instrumentation Laboratory Electra 1600/C
  Instrumentation Laboratory Electra 1800C
  Instrumentation Laboratory Futura
  ITC Hemochron 8000
  Roche Diagnostics CoaguChek
  Siemens BCS
  Siemens BCT
  Siemens BF II/Fibrintimer Series
  Sysmex CA-50
  Sysmex CA-500
  Sysmex CA-1500
  Sysmex CA-5000/CA-1000
  Sysmex CA-6000
  Sysmex CA-7000
  Teco Coatron II/Jr./AccuStasis 5000
  Trinity Biotech Amax CS190
  Trinity Biotech Amax CS400
  Trinity Biotech Coag-A-Mate Max
  Trinity Biotech KC 40, 4A, 1A Series
  Trinity Biotech MDA 180
  Trinity Biotech Coag-A-Mate MTX
  Trinity Biotech Coag-A-Mate RA4
  Trinity Biotech Coag-A-Mate XC/Plus
  Trinity Biotech Coag-A-Mate XM
D. Major in Vitro Diagnostic Technologies and Their Potential Applications
  1. Chromogenic Substrates
  2. Monoclonal and Polyclonal Antibodies
  3. Immunoassays
    a. Applications
    b. Technological Principle
    c. Enzyme Immunoassays (EIA)
      Overview
      ELISA
      EMIT
      Dot Immunobinding Assays
      Capillary Immunoassays
      Enzyme Amplification
      Electrochemical Immunoassay
    d. Fluorescent Immunoassays
      Fluorescence Polarization
      Time-Resolved Pulse Fluorescence
      Fluorescence Lifetime
    e. Latex Agglutination
    f. Immunoprecipitation
  4. Microcomputers
  5. Automation
  6. Robotics
  7. DNA Probes
    a. Overview
    b. Amplification Methods
      PCR
      Ligase Chain Reaction
      Branched DNA
      Q-Beta Replicase
      NASBA
      SDA
      3 SR
      HPA
      Two-Tiered System
      LAT
  8. Artificial Intelligence
  9. Dry Chemistry
  10. Biosensors

III. FRANCE: TEST VOLUME FORECASTS BY MARKET SEGMENT

IV. GERMANY: TEST VOLUME FORECASTS BY MARKET SEGMENT

V. ITALY: TEST VOLUME FORECASTS BY MARKET SEGMENT

VI. JAPAN: TEST VOLUME FORECASTS BY MARKET SEGMENT

VII. SPAIN: TEST VOLUME FORECASTS BY MARKET SEGMENT

VIII. UK: TEST VOLUME FORECASTS BY MARKET SEGMENT

IX. USA: TEST VOLUME FORECASTS BY MARKET SEGMENT

X. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS

XI. ALTERNATIVE MARKET PENETRATION STRATEGIES

A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
  1. Marketing Approaches
  2. Product Complexity
  3. Customer Preference
  4. Established Suppliers
  5. Emerging Suppliers
  6. Major Types Of Distributors
  7. Market Segmentation

XII. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

XIII. COMPETITIVE ASSESSMENTS

Abbott
American Diagnostica
Avocet Medical
Axis-Shield
Beckman Coulter
Becton Dickinson
Bio/Data Corporation
Biosite
Chrono-Log
Corgenix Medical
Diagnostica Stago
Helena Laboratories
HYPEN BioMed
Instrumentation Laboratory
ITC
Nanogen
Roche
Siemens
Sienco
Sysmex
Thermo Fischer
Trinity Biotech
ZyCare
APTT: US, EUROPE, JAPAN
Test Volume Forecasts by Country and Market Segment

LIST OF TABLES

Major Companies Developing or Marketing APTT Tests
France
APTT Test Volume Forecasts by Market Segment
Germany
APTT Test Volume Forecasts by Market Segment
Italy
APTT Test Volume Forecasts by Market Segment
Japan
APTT Test Volume Forecasts by Market Segment
Spain
APTT Test Volume Forecasts by Market Segment
U.K.
APTT Test Volume Forecasts by Market Segment
U.S.A.
APTT Test Volume Forecasts by Market Segment

Ask Your Question

Innovative APTT Diagnostic Testing Technologies and Emerging Markets
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: